Future Genomics Technologies specializes in advanced genomics and transcriptomics, offering a wide array of custom services tailored to meet the needs of various sectors, including biotechnology, pharmaceuticals, and agriculture. Their expertise encompasses de novo genome sequence assembly, which involves the complete process from DNA extraction to the creation of annotated genome sequences. They are capable of handling complex genomes, including those of animals, plants, and microbes, and can perform full-length organelle genome sequencing as well as transcriptome sequencing. Their services also include differential gene expression analysis, structural and functional genome annotation, and transgene characterization, which is essential for regulatory compliance in transgenic organisms.

The company utilizes cutting-edge Next Generation Sequencing (NGS) technologies, particularly those developed by Oxford Nanopore Technologies and Illumina, to enhance the accuracy and efficiency of genomic analysis. Their innovative approaches have led to significant achievements, such as the successful sequencing of the King cobra genome, which highlighted the importance of long-read sequencing for resolving complex genomic regions. Future Genomics Technologies is recognized as one of the first certified sequencing providers for Oxford Nanopore Technologies, reflecting their commitment to leveraging the latest advancements in genomics to provide high-quality, detailed genetic insights for their clients.

Netherlands

New DNA technologies are rapidly being developed and will have an increasing impact on the world and on people's daily life. Future Genomics Technologies aims to translate academic knowledge and novel technologies into usable applications and provide early and easy access to these applications. Our mission is to help you achieve your goals using cutting edge sequencing and bioinformatics technology.

Future Genomics Technologies

Company Details